Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

195
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

17
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
17
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

290
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An engineered probiotic co-expressing dual melanoma epitopes for therapeutic cancer vaccination.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Rare 19q13.42 duplication encompassing <i>PRKCG</i> associated with neurodevelopmental abnormalities.

Translational pediatrics·2026
Same author

Machine learning-based genome-wide association analysis to construct a clinical decision model for severe neonatal jaundice.

Translational pediatrics·2026
Same author

Spatial and temporal single cell multi-omics in mice reveals macrophage-SFRP4+ stroma interactions promoting endometrial regeneration via TNF-α.

Cell reports·2026
Same author

Platelet-derived vesicles restore fertility in endometrial injury by modulating the endometrial immune niche in mice.

Science advances·2026
Same author

The formation and function of intercellular bridges in male germlines.

Communications biology·2026

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

906

Diagnostic biomolecules and combination therapy for pre-eclampsia.

Jingqi Qi1,2, Bingbing Wu1, Xiuying Chen1

  • 1International Institutes of Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, No. N1, Shangcheng Avenue, Yiwu, 322000, China.

Reproductive Biology and Endocrinology : RB&E
|September 6, 2022
PubMed
Summary

Accurate diagnosis of pre-eclampsia (PE) is crucial for optimizing maternal and fetal outcomes. This review explores biochemical markers for early PE prediction and interventions to improve clinical management.

Keywords:
BiomarkersDiagnosisPreeclampsiaTherapeutics

More Related Videos

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

13.9K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

906
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

13.9K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Biochemical Diagnostics

Background:

  • Pre-eclampsia (PE) is a leading cause of maternal and perinatal mortality, linked to placental malperfusion and endothelial injury.
  • Current diagnostic methods for PE, including maternal characteristics and biophysical markers, have limitations in precision.
  • No pharmaceutical intervention currently halts PE progression, emphasizing the need for early diagnosis and management.

Purpose of the Study:

  • To review advancements in biochemical prediction of pre-eclampsia.
  • To explore interventions aimed at ameliorating PE disease progression.
  • To provide references for improved clinical diagnosis and treatment of PE.

Main Methods:

  • Literature review focusing on biochemical factors in PE development.
  • Analysis of current diagnostic targets based on PE pathogenesis and molecular phenotypes.
  • Examination of interventions associated with biochemical markers for PE.

Main Results:

  • Biochemical factor research has identified potential diagnostic targets for PE.
  • Early and precise diagnosis of PE can optimize outcomes through expectant management.
  • Developments in biochemical prediction offer new avenues for clinical application.

Conclusions:

  • Enhanced biochemical prediction of PE is critical for timely intervention.
  • Targeted interventions based on biochemical markers may improve maternal and fetal outcomes.
  • Further research is needed to translate biochemical findings into effective clinical practice for PE management.